About 11 Trademarks found that are owned by Fosun Pharma Usa Inc.

The mark consists of the blue word FUSION in capitalized text, with the orange word BIOVENTURE to its right, oriented vertically, all above the blue text FOSUN PHARMA US INNOVATION HUB, which is next to a small blue triangle. The O in FUSION is displayed around a stylized flame comprising an orange semi-circular shape at the bottom, a set of three gradient orange and yellow vertical lines in the middle, and a grid of fifteen orange dots at the top. The areas shown in white are for background only and are not claimed as part of the mark.

Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies

Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies

"BIOVENTURE"

Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation

Biochemical research and development; Biotechnology research; Gene therapy research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the field of gene therapy, namely, development of oligonucleotides that target more than one aspect of the RNA transcript splicing regulation machinery and process to enhance the potentiation or inhibition of that machinery and process; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation

Biochemical research and development; Biotechnology research; Gene therapy research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the field of gene therapy, namely, using knowledge of the RNA transcript splicing regulation machinery to improve efficacy; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation

"ASO"

The mark consists of a dark purple right-angled polygon to the bottom left of a series of three identical but directionally opposite right-angled polygons of small, medium and large sizes. The small polygon of the three is turquoise, the medium polygon of the three is indigo, and the large polygon of the three is pink. Negative space between each of the polygons is white. White areas around the outside of the polygons are for background purposes only and are not claimed as part of the mark.

Pharmaceutical preparations for the treatment of small-cell lung cancer; Pharmaceutical preparations for the treatment of cancer

Drug discovery services; Research and development in the field of design of RNA-targeted drugs

The mark consists of the word LEVERNA in gradient blue and gradient gray stylized font, wherein the letters E, V, and E comprise a stylized electrocardiogram symbol, all above the word THERAPEUTICS in smaller gray stylized font. Areas in white are for background only and are not claimed as part of the mark.

Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy